BioSpace News Archive

Witness the next wave of digital transformation in Asia

Annual Award Recognizes Transformative Breakthroughs in Vision Research

Cannabis Facility Leasing, Management and Licensing Fees Power Q2 Results

Service Corporation International announced that its Board of Directors has approved a quarterly cash dividend of seventeen cents per share of common stock.

According to the latest update from Spherix Global Insights, while dermatologists continue to report high satisfaction with the first FDA approved biologic, there is still a large unmet need for new pharmacologic treatments for atopic dermatitis.

Rich Wasielewski, president and CEO of Nortech Systems, Inc. (NASDAQ: NSYS), today announced he will be retiring.

Health system to integrate Playback Health’s software technology into its digital patient experience and branding strategy

98,000-square-foot training facility triples training capacity and offers seven fully equipped studios for livestreamed courses across U.S. and Canada via internet

Kansas City is the bustling center of the global animal health industry and regarded as the world’s best place to advance new technologies and solutions to solve global issues.

Ultragenyx Pharmaceutical Inc.(NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that the first patient has been dosed in the Phase 1/2 study of DTX401, an adeno-associated virus vector based gene therapy for the treatment of patients with glycogen storage disease type Ia (GSDIa).